Polyamine compounds for treating chemokine receptor mediated...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S426000, C514S601000, C514S617000, C514S639000, C514S561000, C514S649000

Reexamination Certificate

active

10814058

ABSTRACT:
This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of the following formula. Each variable in this formula is defined in the specification.

REFERENCES:
patent: 5252317 (1993-10-01), Keana
patent: 5567411 (1996-10-01), Keana et al.
patent: 5719193 (1998-02-01), Bowlin et al.
patent: 5910513 (1999-06-01), Galey
patent: 2005/0165063 (2005-07-01), Yamazaki et al.
patent: 62129858 (1987-06-01), None
patent: 64-66117 (1989-03-01), None
patent: 1-272568 (1989-10-01), None
patent: 2002-543126 (2002-12-01), None
patent: 3714948 (2005-09-01), None
patent: WO 97/00245 (1997-01-01), None
patent: WO 00/02870 (2000-01-01), None
patent: WO 00/56729 (2000-09-01), None
patent: WO 00/66112 (2000-11-01), None
patent: WO 02/22600 (2002-03-01), None
patent: WO 02/055112 (2002-07-01), None
patent: WO 02/083143 (2002-10-01), None
Wuntz, T.P. et al., J. Med. Chem., vol. 33, No. 6, pp. 1549-1553, 1990.
Mohamadou et al., “Synthesis and Characterisation of Zinc(II) Complexes of Tripodal N7Ligands Involving Pyridine and Amine or Amide Nitrogen Donors. Crystal Structure of a Zine (II) Complex”, J. Chem. Soc., Dalton Trans., 3320-3328, 2001.
Rannard et al., “The Selective Reaction of Primary Amines with Carbonyl Imidazole Containing Compounds: Selective Amide and Carbamate Synthesis”, Org. Lett., 2:2117-2120, 2000.
Xu et al., “Specific Sequestering Agents for the Actinides. 28. Synthesis and Initial evaluation of Multidentate 4-Crabamoyl-3-hydroxy-1-methyl-2(1H)-pyridinone Ligands for in Vivo Plutonium (IV) Chelation”, J. Med. Chem. 38:2606-2614, 1995.
Yu et al., “Study on Antioxidative Succinimide Dispersants,”Chemical Abstracts Service, [Online] XP002452292, Abstract.
Tecilla et al. “Acceleration o p-Nitrophenyl Ester Cleavage by Zn (II)-Organized Molecular Receptors,”Journal of Organic Chemistry, vol. 62, pp. 7621-7628 (1997) XP002452260.
Deroche et al., “A seven-Coordinate Manganese (II) Complex Formed with a Single Tripodal Heptadentate Ligand as a New Superoxide Scavenger,”Journal of the American Chemical Society, vol. 118, No. 19, pp. 4567-4573 (1996) XP002452261.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Polyamine compounds for treating chemokine receptor mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polyamine compounds for treating chemokine receptor mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polyamine compounds for treating chemokine receptor mediated... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3922826

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.